Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report

Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report

Background and objectives: The aim of this study was to report a case of a patient with Charcot-Marie-Tooth disease type 2 (CMT2) treated with epigallocatechin gallate (EGCG) for 4 months in order to assess its therapeutic potential in CMT2. Materials and Methods: The study included a brother and a...

詳細記述

書誌詳細
主要な著者: Bustos, Antonio, Selvi Sabater, Pablo, Benlloch, María, Drehmer, Eraci, López-Rodríguez, María Mar, Platero, Felix, Platero, Jose Luis, Escribá-Alepuz, Jesús, Rubia Ortí, Jose Enrique de la
フォーマット: info:eu-repo/semantics/article
言語:cat
出版事項: MDPI 2021
主題:
Charcot-Marie-Tooth disease type 2
epigallocatechin gallate
IL-6
motor activity
paraoxonase 1
オンライン･アクセス:http://hdl.handle.net/10835/9523

インターネット

http://hdl.handle.net/10835/9523

類似資料